Thromb Haemost 1985; 54(02): 544-546
DOI: 10.1055/s-0038-1657893
Original Article
Schattauer GmbH Stuttgart

Enhanced “In Vitro“ Release of Platelet α-Granules After Acute Myocardial Infarction (AMI)

V Pengo
The Department of Cardiology, Padua University, Padua, Italy
,
M Boschello
The Department of Cardiology, Padua University, Padua, Italy
,
P Prandoni
The Department of Cardiology, Padua University, Padua, Italy
,
R Schiavon
The Department of Cardiology, Padua University, Padua, Italy
,
F Bellotto
The Department of Cardiology, Padua University, Padua, Italy
,
L Schivazappa
The Department of Cardiology, Padua University, Padua, Italy
,
S Dalla Volta
The Department of Cardiology, Padua University, Padua, Italy
› Author Affiliations
Further Information

Publication History

Received 31 October 1984

Accepted 09 March 1985

Publication Date:
18 July 2018 (online)

Summary

In vivo platelet activity was studied in 58 patients with AMI on admittance to the Coronary Care Unit, in 48 of these patients after 1 week, in 30 after 1 month and in 24 patients after 6 months. Patients were carefully selected and excluded if they had associated diseases known to increase platelet activity. In vivo activation was studied by evaluating the plasma concentration of beta-thromboglobulin (β-TG) and platelet factor 4 (PF4) in the same blood sample. On admittance (x = 58.5) and on day 7 (x = 52.9) β-TG values were significantly higher than those obtained in the control group (x = 29). β-TG values were moderately elevated after 1 month (x = 37.7) and then returned to values similar to those of the control group after 6 months (x = 27.9). The simultaneous assessment of PF4 shows a β-TG/PF4 ratio indicative for in vitro release (≤2.5) in many patients on days 1 and 7. Moreover, the β-TG/PF4 ratio in patients with AMI tends towards 2 when β-TG values are high. These results may indicate a greater tendency to an in vitro platelet release in the acute phase of AMI.

 
  • References

  • 1 Turpie AGG, de Boer AC, Genton E. Platelet consumption in cardiovascular disease. Semin Thromb Haemostas 1982; 08: 161-185
  • 2 Kaplan KL, Owen J. Plasma level of β-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981; 57: 199-202
  • 3 Ludlam CA, Cash JD. Studies on the liberation of β-thromboglobulin from human platelets in vitro. Br J Haematol 1976; 33: 239-247
  • 4 Nossel HL, Wasser J, Kaplan KL, La Gamma KS, Yudelman I, Canfield RE. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline. J Clin Invest 1979; 64: 1371-1378
  • 5 Musial J, Neviarowski S, Edmunds LH, Addonizio VP, Nicolau KC, Colman RW. In vivo release and turnover of secreted platelet antiheparin proteins in Rhesus Monkey (Macaca Mulatta). Blood 1980; 56: 596-603
  • 6 Rasi V, Ikkala E, Torstilla I. Plasma β-thromboglobulin in acute myocardial infarction. Thromb Res 1982; 25: 203-212
  • 7 Handin R, McDonough M, Lesch M. Elevation of platelet factor 4 in acute myocardial infarction: measurement by radioimmunoassay. J Lab Clin Med 1978; 91: 340-348
  • 8 Levine SP, Lindenfeld J, Ellis JB, Raymond NM, Krentz LS. Increased plasma concentration of platelet factor 4 in coronary artery disease. Circulation 1981; 64: 626-631
  • 9 Wadenvik H, Eriksson KA, Safai-Kutti S, Swedberg K, Kutti J. Plasma concentration of platelet factor 4 in acute myocardial infarction. Scand J Haematol 1981; 26: 359-363
  • 10 Hughes A, Daunt S, Vass G, Wickes J. In vivo platelet activation following myocardial infarction and acute coronary ischemia. Thromb Haemostas 1982; 48: 133-135
  • 11 Van Hulsteijn H, Kolff F, Briet E, Van der Laarse A, Bertina R. Fibrinopeptide A and β-thromboglobulin in patients with angina pectoris and acute myocardial infarction. Am Heart J 1984; 107: 39-45
  • 12 Pumphrey CW, Dawes J. Plasma β-thromboglobulin as a measure of platelet activity. Am J Cardiol 1982; 50: 1258-1261
  • 13 Smitherman TC, Milam M, Woo J, Willerson JT, Frenkel EP. Elevated beta-thromboglobulin in peripheral venous blood of patients with acute myocardial ischemia: direct evidence for enhanced platelet reactivity in vivo. Am J Cardiol 1981; 48: 395-402
  • 14 O’Brien JR, Therington E, Shuttle Worth R. Beta-thromboglobulin and heparin neutralizing activity test in clinical conditions. Lancet 1977; 01: 1153-1154
  • 15 Denham MJ, Fisher M, James G, Hassan M. Beta-thromboglobulin and myocardial infarction (Letter). Lancet 1977; 01: 1154
  • 16 Mehta P, Mehta J. Platelet function studies in coronary artery disease. V. Evidence for enhanced platelet microthrombus formation activity in acute myocardial infarction. Am J Cardiol 1979; 43: 757-760
  • 17 Schwartz MB, Hawiger J, Timmons S, Friesinger GC. Platelet aggregates in ischaemic heart disease. Thromb Haemostas 1980; 43: 185-188
  • 18 Kohanna FH, Smith MH, Salzman EW. Do patients with thromboembolic disease have circulating platelet aggregates?. Blood 1984; 64: 205-209
  • 19 Sorkin RP, Tokarsky JM, Huber-Smith MJ, Steiger JF, McCann DS. In vivo platelet aggregation and plasma catecholamines in acute myocardial infarction. Am Heart J 1982; 104: 1255-1261
  • 20 White AM. Contribution of platelet to thrombus formation. Br Med Bull 1978; 34: 123-128
  • 21 Stratton JR, Malpass TW, Ritchie JL, Pfeifer MA, Harker LA. Studies of platelet factor 4 and Beta-thromboglobulin release during exercise: lack of relationship to myocardial ischemia. Circulation 1982; 66: 33-43
  • 22 Douglas JT, Lowe GDO, Forbes CD, Prentice CRM. Plasma fibrinopeptide A and beta-thromboglobulin in patients with chest pain. Thromb Haemostas 1983; 50: 541-542